產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時服務(wù)熱線
產(chǎn)品概述
名稱 | K7M2 wt [K7M2-WT] (小鼠骨肉瘤成骨細(xì)胞) (STR鑒定正確) |
別稱 | K7M2 wt; K7M2 |
種屬 | 小鼠 |
生長特性 | 貼壁細(xì)胞 |
細(xì)胞形態(tài) | 成骨細(xì)胞樣 |
凍存條件 | 凍存液:55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度:液氮 |
培養(yǎng)方案A(默認(rèn)) |
培養(yǎng)條件:
氣相:空氣,95%;CO2,5%, 溫度:37℃
|
推薦傳代比例 | 1:3-1:6 |
推薦換液頻率 | 2-3次/周 |
背景描述 | K7M2 wt [K7M2-WT]細(xì)胞抗原表達(dá):Ⅷ因子、整合唾液酸蛋白(BSP)、二聚糖、飾膠蛋白聚糖、絨毛蛋白。此外,骨唾液酸蛋白、二聚糖、飾膠蛋白聚糖和骨調(diào)素的表達(dá)顯示K7M2 wt [K7M2-WT]細(xì)胞骨家族細(xì)胞特性。 |
年齡(性別) | 雌性;成年 |
組織來源 | 品系:BALB/c;器官:骨;疾病:骨肉瘤;來源轉(zhuǎn)移灶:肺;細(xì)胞類型:成骨細(xì)胞 |
細(xì)胞類型 | 腫瘤細(xì)胞 |
腫瘤類型 | 肉瘤細(xì)胞 |
生物安全等級 | BSL-1 |
倍增時間 | ~31 hours |
致瘤性 | Yes, forms tumors in BALB/c mice with spontaneous metastasis to the lungs in over 90% of mice inoculated. |
抗原表達(dá)情況 | CD31+ |
基因表達(dá)情況 | secreted phosphoprotein 1 (osteopontin); factor VIII |
保藏機(jī)構(gòu) | ATCC; CRL-2836 |
STR鑒定
-
STR位點(diǎn)信息
18-3 18 6-7 12 5-5 14 X-1 25 1-2 17 7-1 29 8-1 13,14 1-1 16 19-2 13 15-3 22.3 12-1 17 6-4 18 4-2 21.3 3-2 12,13 2-1 16 13-1 16.2
11-2 18 17-2 16,17 -
STR鑒定圖
-
參考文獻(xiàn)
-
Aptamer-modified melittin micelles efficiently inhibit osteosarcoma deterioration by inducing immunogenic cell death (2025-01-13)
期刊:COLLOIDS AND SURFACES B-BIOINTERFACES
DOI:10.1016/j.colsurfb.2025.114512
影響因子 :5.4
引用產(chǎn)品: K7M2 wt [K7M2-WT] 細(xì)胞
-
A bone-targeting permeable nanomicelle acting as an icebreaker for enhancing chemotherapy of osteosarcoma (2024-03-29)
期刊:CHEMICAL ENGINEERING JOURNAL
影響因子 :15.1
引用產(chǎn)品: K7M2 wt [K7M2-WT] 細(xì)胞
-
Tumor-oriented and chemo-photothermal nanoplatform capable of sensitizing chemotherapy and ferroptosis against osteosarcoma metastasis (2024-05-08)
期刊:INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
DOI:10.1016/j.ijbiomac.2024.132019
影響因子 :8.2
引用產(chǎn)品: MC3T3-E1 Subclone 24 (新引進(jìn)) 細(xì)胞 , K7M2 wt [K7M2-WT] 細(xì)胞
-
Investigating the synergy of Shikonin and Valproic acid in inducing apoptosis of osteosarcoma cells via ROS-mediated EGR1 expression (2024-02-15)
期刊:PHYTOMEDICINE
DOI:10.1016/j.phymed.2024.155459
影響因子 :7.9
引用產(chǎn)品: HOS 細(xì)胞 , K7M2 wt [K7M2-WT] 細(xì)胞 , DMEM高糖 培養(yǎng)基
-
In situ biomineralization reinforcing anisotropic nanocellulose scaffolds for guiding the differentiation of bone marrow-derived mesenchymal stem cells (2024-06-27)
期刊:INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
DOI:10.1016/j.ijbiomac.2024.133515
影響因子 :7.7
引用產(chǎn)品: K7M2 wt [K7M2-WT] 細(xì)胞 , 小鼠骨髓間充質(zhì)干細(xì)胞
-
Injectable thermosensitive black phosphorus nanosheet- and doxorubicin-loaded hydrogel for synergistic bone tumor photothermal-chemotherapy and osteogenesis enhancement (2023-03-25)
期刊:INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
DOI:10.1016/j.ijbiomac.2023.124209
影響因子 :8.2
引用產(chǎn)品: MC3T3-E1 Subclone 24 細(xì)胞 , 人臍靜脈內(nèi)皮細(xì)胞 , NCTC clone 929 [L 細(xì)胞, L-929] 細(xì)胞 , K7M2 wt [K7M2-WT] 細(xì)胞
-
Sulfatinib, a novel multi-targeted tyrosine kinase inhibitor of FGFR1, CSF1R, and VEGFR1–3, suppresses osteosarcoma proliferation and invasion via dual role in tumor cells and tumor microenvironment (2023-06-08)
期刊:Frontiers in Oncology
影響因子 :4.7
引用產(chǎn)品: MG-63 細(xì)胞 , U-2 OS [U2OS] 細(xì)胞 , HOS 細(xì)胞 , K7M2 wt [K7M2-WT] 細(xì)胞 , RAW 264.7 細(xì)胞
-
LPS combined with CD47mAb enhances the anti?osteosarcoma ability of macrophages (2023-03-28)
期刊:Oncology Letters
影響因子 :2.9
引用產(chǎn)品: RAW 264.7 細(xì)胞 , K7M2 wt [K7M2-WT] 細(xì)胞 , U-2 OS [U2OS] 細(xì)胞 , MG-63 細(xì)胞
-
Nanoengineering a metal–organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells (2022-05-03)
期刊:JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
DOI:10.1186/s13046-022-02372-8
影響因子 :11.3
引用產(chǎn)品: K7M2 wt [K7M2-WT] 細(xì)胞
-
MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression (2022-01-12)
期刊:OncoImmunology
DOI:10.1080/2162402X.2021.2024941
影響因子 :7.2
引用產(chǎn)品: RAW 264.7 細(xì)胞 , K7M2 wt [K7M2-WT] 細(xì)胞 , NIH/3T3 細(xì)胞 , 293T [HEK-293T] 細(xì)胞
-
Pharmacodynamics and pharmacokinetics of PLGA-based doxorubicin-loaded implants for tumor therapy (2022-02-11)
期刊:Drug Delivery
DOI:10.1080/10717544.2022.2032878
影響因子 :6.0
引用產(chǎn)品: K7M2 wt [K7M2-WT] 細(xì)胞
FAQs
Q:{{item.question}}
A:
產(chǎn)品資料


識別碼示意圖